Cytopathological mechanisms in mitochondrial disease

Current Chemical Biology

Volumn 4, Issue 1, 2010, Pages 32-48

  Francione, Lisa ^a   Fisher, Paul R ^a  

^a LA TROBE UNIVERSITY   (Australia)

Author keywords

Ageing; AMPK; Calcium signalling; Mitochondrial disease; Pathogenic mechanisms; ROS

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMPICILLIN; ANTIOXIDANT; CELL NUCLEUS DNA; MITOCHONDRIAL DNA; REACTIVE OXYGEN METABOLITE;

AGING; ALZHEIMER DISEASE; APOPTOSIS; CALCIUM HOMEOSTASIS; CALCIUM INTAKE; CALCIUM TRANSPORT; CALORIC RESTRICTION; CELL FUNCTION; CELL STRESS; CYTOPATHOLOGY; DIABETES MELLITUS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENERGY RESOURCE; HUMAN; LEBER HEREDITARY OPTIC NEUROPATHY; MELAS SYNDROME; MERRF SYNDROME; NARP SYNDROME; NONHUMAN; OPTIC NERVE DISEASE; OXIDATIVE STRESS; PARKINSON DISEASE; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SYMPTOM; TISSUE;

EID: 77950844792     PISSN: 18723136     EISSN: None     Source Type: Journal    
DOI: 10.2174/187231310790226224     Document Type: Review

References (371)

1. Vilarinho L, Santorelli FM, Rosas MJ, Tavares C, Melo-Pires M, DiMauro S. The mitochondrial A3243G mutation presenting as severe cardiomyopathy. J Med Genet 1997; 34: 607-609
2. Koga Y, Akita Y, Takane N, Sato Y, Kato H. Heterogeneous presentation in A3243G mutation in the mitochondrial tRNA(Leu(UUR)) gene. Arch Dis Child 2000; 82: 407-411
3. Chae JH, Hwang H, Lim BC, Cheong HI, Hwang YS, Kim KJ. Clinical features of A3243G mitochondrial tRNA mutation. Brain Dev 2004; 26: 459-462
4. Ueki I, Koga Y, Povalko N, et al. Mitochondrial tRNA gene mutations in patients having mitochondrial disease with lactic acidosis. Mitochondrion 2006; 6: 29-36.
5. Yang YL, Sun F, Zhang Y, et al. Clinical and laboratory survey of 65 Chinese patients with Leigh syndrome. Chin Med J 2006; 5: 373-377.
6. Dionisi-Vici C, Seneca S, Zeviani M, et al. Fulminant Leigh syndrome and sudden unexpected death in a family with the T9176C mutation of the mitochondrial ATPase 6 gene. J Inherit Metab Dis 1998; 21: 2-8.
7. Makino M, Horai S, Goto Y, Nonaka I. Confirmation that a T-to-C mutation at 9176 in mitochondrial DNA is an additional candidate mutation for Leigh's syndrome. Neuromuscul Disord 1998; 8: 149-151
8. Carrozzo R, Murray J, Santorelli FM, Capaldi RA. The T9176G mutation of human mtDNA gives a fully assembled but inactive ATP synthase when modeled in Escherichia coli. FEBS Lett 2000; 486: 297-299
9. Enns GM, Bai RK, Beck AE, Wong LJ. Molecular-clinical correlations in a family with variable tissue mitochondrial DNA T8993G mutant load. Mol Genet Metab 2006; 88: 364-371.
10. Moslemi AR, Darin N, Tulinius M, Oldfors A, Holme, E. Two new mutations in the MTATP6 gene associated with Leigh syndrome. Neuropediatrics 2005; 36: 314-318
11. Wallace DC, Lott MT. MITOMAP: a human mitochondrial genome database. 2006; http://www.mitomap.org.
12. Castagna AE, Addis J, McInnes RR, et al. Late onset Leigh syndrome and ataxia due to a T to C mutation at bp 9,185 of mitochondrial DNA. Am J Med Genet 2007; 143: 808-816
13. Rossignol R, Faustin B, Rocher C, Malgat M, Mazat J, Letellier T. Mitochondrial threshold effects. Biochem J 2003; 370: 751-62.
14. Wallace DC, Zheng X, Lott MT, et al. Familial mitochondrial encephalomyopathy (MERRF): genetic, pathophysiological, and biochemical characterization of a mitochondrial DNA disease. Cell 1988; 55: 601-610
15. Wallace DC, Singh G, Lott MT, et al. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 1988; 242: 1427-1430
16. Goto T, Horoai S, Matsuoka T, et al. Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS): A correlative study of the clinical features and mitochondrial DNA mutation. Neurology 1992; 42: 545-550
17. Tatuch Y, Robinson BH. The mitochondrial DNA mutation at 8993 associated with NARP slows the rate of ATP synthesis in isolated lymphoblast mitochondria. Biochem Biophys Res Commun 1993; 192: 124-128
18. Mackey DA, Oostra RJ, Rosenberg T, et al. Primary pathogenic mtDNA mutations in multigeneration pedigrees with Leber hereditary optic neuropathy. Am J Hum Genet 1996; 59: 481-485
19. Geromel V, Kadhom N, Cebalos-Picot I, et al. Superoxide-induced massive apoptosis in cultured fibroblasts harboring the neurogenic ataxia retinitis pigmentosa (NARP) mutation in the ATPase-6 gene of the mitochondrial DNA. Hum Mol Genet 2001; 10: 1221-1228
20. McKenzie M, Liolista D, Hanna MG. Mitochondrial disease: Mutations and mechanisms. Neurochem Res 2004; 29: 589-600.
21. Kujoth GC, Hiona A, Pugh TD, et al. Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 2005; 309: 481-484
22. Kujoth GC, Leeuwenburgh C, Prolla TA. Mitochondrial DNA mutations and apoptosis in mammalian aging. Cancer Res 2006; 66: 7386-7389
23. Lin MT, Beal MF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 2006; 443: 787-795
24. Thyagarajan D, Bressman S, Shanske S, DiMauro S, Fahn S. A novel T1095C mutation in the mitochondrial 12s ribosomal RNA gene. Neurology 1997; 48: A444.
25. Simon DK, Pulst SM, Sutton JP, Browne SE, Beal MF, Johns DR. Familial multisystem degeneration with parkinsonism associated with the 11778 mitochondrial DNA mutation. Neurology 1999; 53: 1787-1793
26. Coskun PE, Beal MF, Wallace DC. Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochon-drial transcription and replication. Proc Natl Acad Sci USA 2004; 101: 10726-10731
27. Bender A, Krishnan KJ, Morris CM, et al. High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat Genet 2006; 38: 515-517
28. Hamblet NS, Ragland B, Ali M, Conyers B, Castora FJ. Mutations in mitochondrial-encoded cytochrome c oxidase subunits I, II, and III genes detected in Alzheimer's disease using single-strand conformation polymorphism. Electrophoresis 2006; 27: 398-408.
29. Kraytsberg Y, Kudryavtseva E, McKee AC, Geula C, Kowall NW, Khrapko K. Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons. Nat Genet 2006; 38: 518-520
30. lys. Neurology 2007; 68: 56-58
31. Albers DS, Beal MF. Mitochondrial dysfunction and oxidative stress in aging and neurodegenerative disease. J Neural Transm Suppl 2000; 59: 133-154
32. Perry G, Nunomura A, Friedlich AL, et al. In: Factors controlling oxidative damage in Alzheimer disease: metals and mitochondria. Free Radicals in Chemistry, Biology and Medicine. London, OICA International 2000; 417-423
33. Rao AV, Balachandran B. Role of oxidative stress and antioxidants in neurodegenerative diseases. Nutr Neurosci 2002; 5: 291-309.
34. Goedert M, Spillantini MG. A century of Alzheimer's disease. Science 2006; 314: 777-781
35. Stichel CC, Zhu X, Bader V, Linnartz B, Schmidt S, Lubbert H. Mono-and double-mutant mouse models of Parkinson's disease display severe mitochondrial damage. Hum Mol Genet 2007; 16: 2377-2393
36. Kadowaki H, Tobe K, Mori Y, et al. Mitochondrial gene mutation and insulin-deficient type of diabetes mellitus. Lancet 1993; 341: 893-894
37. Berkovic SF, Shoubridge EA, Anderman F, Anderman E, Carpenter S, Karpati G. Clinical spectrum of mitochondrial DNA muata-tion at base pair 8344. Lancet 1991; 338: 457.
38. lys mutation in the mtDNA is the casual genetic lesion underlaying myoclonic epilepsy and ragged-red fiber (MERRF) syndrome. Am J Hum Genet 1991; 49: 715-722
39. DiMauro S, Schon EA. Mitochondrial DNA mutations in human disease. Am J Med Genet 2001; 106: 18-26.
40. Shahwan A, Farrell M, Delanty N. Progressive myoclonic epilepsies: a review of genetic and therapeutic aspects. Lancet Neurol 2005; 4: 239-248
41. Ciafaloni E, Ricci E, Shanske S, et al. MELAS: clinical features, biochemistry, and molecular genetics. Ann Neurol 1992; 31: 391-398
42. Schon EA, Bonilla E, DiMauro S. Mitochondrial DNA mutations and pathogenesis. J Bioenerg Biomembr 1997; 29: 131-149
43. Baracca A, Sgarbi G, Mattiazzi M, et al. Biochemical phenotypes associated with the mitochondrial ATP6 gene mutations at nt8993. Biochim Biophys Acta -Bioenergetics 2007; 1767: 913-919
44. Jung J, Mauguiere F, Clerc-Renaud P, Ollagnon E, de Camaret BM, Ryvlin P. NARP Mitochondriopathy: An unusual cause of progressive myclonic epilepsy. Neurology 2007; 68: 1429-1430
45. Shoffner J M, Fernhoff M, Krawiecki N, et al. Subacute necrotiz-ing encephalopathy: Oxidative phosphorylation defects and the ATPase 6 point mutation. Neurology 1992; 42: 2168-2174
46. Ortiz RG, Newman NJ, Shoffner JM, Kaufman AE, Koontz DA, Wallace DC. Variable retinal and neurologic manifestations in patients harboring the mitochondrial DNA 8993 mutation. Arch Oph-thalmol 1993; 111: 1525-1530
47. Ji Y, Zhang A-M, Jia X, et al. Mitochondrial DNA haplogroups M7b1'2 and M8a affect clinical expression of Leber Hereditary Optic Neuropathy in Chinese families with the m.11778G A mutation. Am J Human Genet 2008; 83: 760-768
48. Tatuch Y, Christodoulou J, Feigenbaum A, et al. Heteroplasmic mtDNA mutation (T-G) at 8993 can cause Leigh disease when the percentage of abnormal DNA is high. Am J Hum Genet 1992; 50: 852-858
49. Holt I J, Harding AE, Petty RK, Morgan-Hughes JA. A new mito-chondrial disease associated with mitochondrial DNA hetero-plasmy. Am J Hum Genet 1990; 46: 428-433
50. James AM, Wei YH, Pang CY, Murphy MP. Altered mitochondrial function in fibroblasts containing MELAS or MERRF mitochon-drial DNA mutations. Biochem J 1996; 318: 401-407
51. Jeppesen TD, Schwartz M, Frederiksen AL, Wibrand F, Olsen DB, Vissing J. Muscle phenotype and mutation load in 51 persons with the 3243A>G mitochondrial DNA mutation. Arch Neurol 2006; 63: 1701-1706
52. Shepherd RK, Checcarelli N, Naini A, De Vivo DC, DiMauro S, Sue CM. Measurement of ATP production in mitochondrial disorders. J Inherit Metab Dis 2006; 29: 86-91.
53. James AM, Murphy MP. How mitochondrial damage affects cell function. J Biomed Sci 2002; 9: 475-487
54. Maassen JA, 'T Hart LM, van Essen E, et al. Mitochondrial diabetes. Molecular mechaninsms and clinical presentation. Diabetes 2004; 53: S103-S109.
55. Wong A, Cavelier L, Collins-Schramm HE, et al. Differentiation-specific effects of LHON mutations introduced into neuronal NT2 cells. Hum Mol Genet 2002; 11: 431-438
56. Baretta S, Mattavelli L, Sala G, et al. Leber hereditary optic neuropahty mtDNA mutations disrupt glutamate transport in cybrid cell lines. Brain 2004; 127: 2183-2192
57. Mattiazzi M, Vijayvergiya C, Gajewski CD, et al. The mtDNA T8993G (NARP) mutation results in an impairment of oxidative phosphorylation that can be improved by antioxidants. Hum Mol Genet 2004; 13: 869-879
58. Floreani M, Napoli E, Martinuzzi A, et al. Antioxidant defences in cybrids harboring mtDNA mutations associated with Leber's hereditary optic neuropathy. FEBS J 2005; 272: 1124-1135
59. Shigenaga MK, Hagen TM, Ames BN. Oxidative damage and mitochondrial decay in ageing. Proc Natl Acad Sci USA 1994; 91: 10771-10778
60. Richter C. Oxidative damage to mitochondrial DNA and is relationship to ageing. Int J Biochem Cell Biol 1995; 27: 647-653
61. Yakes FM, van Houten B. Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc Natl Acad Sci USA 1997; 94: 514-519
62. Cadenas E, Davies KJ. Mitochondrial free radical generation, oxidative stress and aging. Free Rad Biol Med 2000; 29: 222-230
63. Fisher PR, Rosenberg LT. Chemiluminescence in Dictyostelium discoideum. FEMS Microbiol Lett 1988; 50: 157-161
64. Firtel RA. Signal transduction pathways controlling multicellular development in Dictyostelium. Trends Genet 1991; 7: 381-388
65. Fisher PR, Karampetsos PD, Wilczynska Z, Rosenberg LT. Oxidative metabolism and heat shock enhanced chemiluminescence in Dictyostelium discoideum. J Cell Sci 1991; 99: 741-750
66. Adler V, Yin Z, Tew KD, Ronai Z. Role of redox potential and reactive oxygen species in stress signaling. Oncogene 1999; 18: 6104-6111
67. Charest A, Wilker EW, McLaughlin ME, et al. ROS fusion tyrosine kinase activates a SH2 domain-containing phosphatase-2/phosphatidylinositol 3-Kinase/mammalian target of rapamycin signaling axis to form glioblastoma in mice. Cancer Res 2006; 66: 7473-7481
68. Chiarugi P, Fiaschi T. Redox signalling in anchorage-dependent cell growth. Cell Signal 2007; 19: 672-682
69. 2 formation by rat heart mitochondria on substrate availability and donor age. J Bioenerg Biomembr 1997; 29: 89-95.
70. Barja G, Herrero A. Localization at complex I and mechanism of the higher free radical production of brain nonsynaptic mitochondria in the short-lived rat than in the longevous pigeon. J Bioenerg Biomembr 1998; 30: 235-243
71. Arnaiz SL, Coronel MF, Boveris A. Nitric oxide, superoxide, and hydrogen peroxide production in brain mitochondria after haloperi-dol treatment. Nitric Oxide 1999; 3: 235-243
72. Jones OTG, Hancock JT. In: Free Radicals in Inflammation, Switzerland, Birkha 2000; 21-46.
73. Gyulkhandanyan AV, Pennefather PS. Shift in the localization of sites of hydrogen peroxide production in brain mitochondria by mi-tochondrial stress. J Neurochem 2004; 90: 405-421
74. Adam-Vizi V. Production of reactive oxygen species in brain mitochondria: contribution by electron transport chain and non-electron transport chain sources. Antioxid Redox Signal 2005; 7: 1140-1149
75. Adam-Vizi V, Chinopoulos C. Bioenergetics and the formation of mitochondrial reactive oxygen species. Trends Pharmacol Sci 2006; 27: 639-645
76. Starkov AA, Fiskum G, Chinopoulos C, et al. Mitochondrial alpha-ketoglutarate dehydrogenase complex generates reactive oxygen species. J Neurosci 2004; 24: 7779-7788
77. Tretter L, Adam-Vizi V. Generation of reactive oxygen species in the reaction catalyzed by alpha-ketoglutarate dehydrogenase. J Neurosci 2004; 24: 7771-7778
78. Tretter L, Adam-Vizi V. Alpha-ketoglutarate dehydrogenase: a target and generator of oxidative stress. Philos Trans R Soc Lond B Biol Sci 2005; 360: 2335-2345
79. Poyton RO, McEwen JE. Crosstalk between nuclear and mitochondrial genomes. Annu Rev Biochem 1996; 65: 563-607.
80. Turrens JF. Superoxide production by the mitochondrial respiratory chain. Biosci Rep 1997; 17: 3-8.
81. Wei YH, Lee HC. Oxidative stress, mitochondrial DNA mutation, and impairment of antioxidant enzymes in aging. Exp Biol Med 2002; 227: 671-682
82. Cooke MS, Evans MD, Dizdaroglu M, Lunec J. Oxidative DNA damage: mechanisms, mutation and disease. FASEB J 2003; 17: 1195-1214. (Pubitemid 36775767)
83. Kang D, Hamasaki N. Mitochondrial oxidative stress and mito-chondrial DNA. Clin Chem Lab Med 2003; 41: 1281-1288
84. Gusdon AM, Votyakova TV, Reynolds IJ, Mathews CE. Nuclear and mitochondrial interaction involving mt-Nd2 leads to increased mitochondrial reactive oxygen species production. J Biol Chem 2007; 282: 5171-5179
85. Boveris A, Oshino N, Chance B. The cellular production of hydrogen peroxide. Biochem J 1972; 128: 617-630
86. Boveris A, Chance B. The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen. Biochem J 1973; 134: 707-716
87. Kirby K, Hu J, Hilliker AJ, Phillips JP. RNA interference-mediated silencing of SOD2 in Drosophila leads to early adult-onset mortality and elevated endogenous oxidative stress. Proc Natl Acad Sci USA 2002; 99: 16162-16167
88. Maier CM, Chen PH. Role of superoxide dismutases in oxidative damage and neurodegenerative disorders. Neuroscientist 2002; 8: 323-334
89. Fridovich I. The biology of oxygen radicals. Science 1978; 201: 875-880
90. Deby C, Goutier R. New perspectives on the biochemistry of superoxide anion and the efficiency of superoxide dismutases. Bio-chem Pharmacol 1990; 39: 399-405.
91. Liddell JR, Hoepken HH, Crack PJ, Robinson SR, Dringen R. Glutathione peroxidase 1 and glutathione are required to protect mouse astrosytes from Iron-mediated hydrogen peroxide toxicity. J Neurosci Res 2006; 84: 578-586
92. Poderoso JJ, Carreras MC, Lisdero C, Riobo N, Schopfer F, Boveris A. Nitric oxide inhibits electron transfer and increases su-peroxide radical production in rat heart mitochondria and submito-chondrial particles. Arch Biochem Biophys 1996; 328: 85-92.
93. Navarro A, Boveris A. The mitochondrial energy transduction system and the aging process. Am J Physiol Cell Physiol 2007; 292: C670-C686.
94. Roy S, Sen CK, Gozin A, Andrieu V, Pasquier C. In: Antioxidants and Redox Regulation of Genes. San Diego, CA: Academic 2000; 265-295
95. Fariss MW, Chan CB, Patel M, Van Houten B, Orrenius, S. Role of mitochondria in toxic oxidative stress. Mol Intervent 2005; 5: 94-111.
96. Chance B, Sies H, Boveris A. A hydroperoxide metabolism in mammalian organs. Physiol Rev 1979; 59: 527-605.
97. Radi R, Turrens JF, Chang LY, Bush KM, Crapo JD, Freeman BA. Detection of catalase in rat heart mitochondria. J Biol Chem 1991; 266: 22028-22034
98. Baud O, Greene AE, Li J, Wang H, Volpe JJ, Rosenberg PA. Glutathione peroxidase-catalase cooperativity is required for resistance to hydrogen peroxide by mature rat oligodendrocytes. J Neurosci 2004; 24: 1531-1540
99. Calabrese V, Guagliano E, Sapienza M, et al. Redox regulation of cellular stress response in aging and neurodegenerative disorders: role of vitagenes. Neurochem Res 2007; 32: 757-773
100. 2 directly activates inositol 1,4,5-triphosphate receptors in endothelial cells. Redox Rep 2005; 10: 29-36.
101. +-ATPase in the rat. Clin Exp Pharmacol Physiol 2006; 33: 1216-1224
102. 2. Proc Natl Acad Sci USA 1997; 94: 11233-11237
103. Tamamura H, Bienfait B, Nacro K, Lewin, NE, Blumberg PM, Marquez VE. Conformationally constrained analogues of diacyl-glycerol (DAG). Contrast between sn-1 and sn-2 DAG lactones in binding to protein Kinase C. J Med Chem 2000; 43: 3209-3217
104. +-ATPase. Acta Biochim Pol 2004; 51: 933-942
105. Dasari A, Bartholomew JN, Volonte D, Galbiati, F. Oxidative stress induces premature senescence by stimulating caveolin-1 gene transcription through p38 mitogen-activated protein kinase/Sp1-mediated activation of two GC-rich promoter elements. Cancer Res 2006; 66: 10805-10814
106. Lu D, Chen J, Hai T. The regulation of ATF3 gene expression by mitogen-activated protein kinases. Biochem J 2007; 401: 559-567
107. Aruoma OI, Colognato R, Fontana I, et al. Molecular effects of fermented papaya preparation on oxidative damage, MAP Kinase activation and modulation of the benzo[a]pyrene mediated genotoxicity. BioFactors 2006; 26: 147-159
108. Ichimura K, Casais C, Peck SC, Shinozaki K, Shirasu K. MEKK1 is required for MPK4 activation and regulates tissue-specific and temperature-dependent cell death in Arabidopsis. J Biol Chem 2006; 281: 36969-36976
109. Kalbina I, Strid A. The role of NADPH oxidase and MAP kinase phosphatase in UV-B-dependent gene expression in Arabidopsis. Plant Cell Environ 2006; 29: 1783-1793
110. Schmid E, El Benna J, Galter D, Klein G, Dröge W. Redox priming of the insulin receptor ß-chain associated with altered tyrosine kinase activity and insulin responsiveness in the absence of tyro-sine autophosphorylation. FASEB J 1998; 12: 863-870
111. Cheng Y, Zhao Q, Liu X, Araki S, Zhang S, Miao J. Phosphatidyl-choline- specific phospholipase C, p53 and ROS in the association of apoptosis and senescence in vascular endothelial cells. FEBS Lett 2006; 580: 4911-4915
112. Pletjushkina OY, Fetisova EK, Lyamzaev KG, et al. Long-distance apoptotic killing of cells is mediated by hydrogen peroxide in a mitochondrial ROS-dependent fashion. Cell Death Differ 2005; 12: 1442-1444
113. Kroemer G, Reed JC. Mitochondrial control of cell death. Nat Med 200; 6: 513-519
114. Danial N, Korsmeyer J. Cell death: Critical control points. Cell 2004; 116: 205-219
115. Kutuk O, Basagna H. Bcl-2 protein family: Implications in vascular apoptosis and atherosclerosis. Apoptosis 2006; 11: 1661-1675
116. shc. Science 2007; 315: 659-663
117. Dickson DW. Apoptotic mechanisms in Alzheimer neurofibrillary degeneration: cause or effect ? J Clin Invest 2004; 114: 23-27.
118. Donath MY, Halban PA. Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications. Diabetologia 2004; 47: 581-589
119. Hajra KM, Liu JR. Apoptosome dysfunction in human cancer. Apoptosis 2004; 9: 691-704.
120. Vaux DL, Korsmeyer SJ. Cell death in development. Cell 1999; 96: 245-254
121. Desagher S, Martinou JC. Mitochondria as the central control point of apoptosis. Trends Cell Biol 2000; 10: 369-377
122. Ashkenazi A, Dixit VM. Death receptors: signalling and modulation. Science 1998; 281: 1305-1308
123. Bodmer JL, Holler N, Reynard S, et al. TRAIL receptor-2 signals apoptosis through FADD and caspase-8. Nature Cell Biol 2000; 2: 241-243
124. Schmitz I, Kirchhoff S, Krammer PH. Regulation of death receptor-mediated apoptosis pathways. Int J Biochem Cell Biol 2000; 32: 1123-1136
125. Söderström TS, Poukkulam M, Holmström TH, Heiskanen KM, Eriksson JE. Mitogen-activated protein kinase/extracellular signal-regulated kinase signaling in activated T cells abrogates TRAIL-induced apoptosis upstream of the mitochondrial amplification loop and caspase-8. J Immunol 2002; 169: 2851-2860
126. Scaffidi C, Fulda S, Srinivasan A, et al. Two CD95 (APO-1/Fas) signalling pathways. EMBO J 1998; 17: 1675-1687
127. Kroemer G, Galluzzi L, Brenner C. Mitochondrial membrane per-meabilization in cell death. Physiol Rev 2007; 87: 99-138.
128. Spierings D, McStay G, Saleh M, et al. Connected to death: the (unexpurgated) mitochondrial pathway of apoptosis. Science 2005; 310: 66-67.
129. Kelekar A, Thompson CB. Bcl-2 Homology Domains: The role of the BH3 domain in apoptosis. Trends Cell Biol 1998; 8: 324-330
130. Adams JM, Cory S. Life-or-death decisions by the Bcl-2 protein family. Trends Biochem Sci 2001; 26: 61-66
131. Sharpe JC, Arnoult D, Youle RJ. Control of mitochondrial permeability by Bcl-2 family members. Biochim Biophys Acta 2004; 1644: 107-113
132. Korsmeyer SJ, Wei MC, Saito M, Weiler S, Oh KJ, Schlesinger PH. Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c. Cell Death Differ 2000; 7: 1166-1173
133. Wei MC, Zong WX, Cheng EHY, et al. Proapoptotic BAX and BAK: A requisite gateway to mitochondrial dysfunction and death. Science 2001; 292: 727-730
134. Yang J, Liu X, Bhalla K, et al. Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked. Science 1997; 275: 1129-1132
135. Kuwana T, Newmeyer DD. Bcl-2-family proteins and the role of mitochondria in apoptosis. Curr Opin Cell Biol 2003; 15: 691-699
136. Danielson SR, Wong A, Carelli V, Martinuzzi A, Schapira AHV, Cortopassi AG. Cells bearing mutations causing Leber's hereditary optic neuropathy are sensitized to Fas-indcued apoptosis. J Biol Chem 2002; 277: 5810-5815
137. Ghelli A, Zanna C, Porcelli AM, et al. Leber's hereditary optic neuropathy (LHON) pathogenic mutations induce mitochondrial-dependent apoptotic death in transmitochondrial cells incubated with galactose medium. J Biol Chem 2003; 278: 4145-4150
138. Mroczek-Tonska K, Kisiel B, Piechota J, Bartnik E. Leber hereditary optic neuropathy - a disease with a known molecular basis but a mysterious mechanism of pathology. J Appl Genet 2003; 44: 529-538
139. Mattiazzi M, Vijayvergiya C, Gajewski CD, et al. The mtDNA T8993G (NARP) mutation results in an impairment of oxidative phosphorylation that can be improved by antioxidants. Hum Mol Genet 2004; 13: 869-79.
140. Rusanan H, Majamaa K, Hassinen IE. Increased activities of anti-oxidant enzymes and decreased ATP concentration in cultured myoblasts with the 3243A- G mutation in mitochondrial DNA. Biochim Biophys Acta 2000; 1500: 10-16
141. Vives-Bauza C, Gonzalo R, Manfredi G, Garcia-Arumi E, Andreu AL. Enhanced ROS production and antioxidant defenses in cybrids harbouring mutations in mtDNA. Neurosci Lett 2006; 391: 136-141
142. Yu WH, Cuervo AM, Kumar A, et al. Macroautophagy -a novel β-amyloid peptide-generating pathway activated in Alzheimer's disease. J Cell Biol 2005; 171: 87-98.
143. Zheng L, Roberg K, Jerhammar F, Marcusson J, Terman A. Auto-phagy of amyloid p-protein in differentiated neuroblastoma cells exposed to oxidative stress. Neurosci Lett 2006; 394: 184-189
144. Moehlmann T, Winkler E, Xia X, et al. Presenilin-1 mutations of leucine 166 equally affect the generation of the Notch and APP intracellular domains independent of their effect on Abeta 42 production. Proc Natl Acad Sci USA 2002; 99: 8025-8030
145. Gu Y, Misonou H, Sato T, Dohmae N, Takio K, Ihara Y. Distinct intramembrane cleavage of the beta-amyloid precursor protein family resembling gamma-secretase-like cleavage of Notch. J Biol Chem 2001; 276: 35235-35238
146. Sastre M, Steiner H, Fuchs K, Capell A, Multhaup G, Condron MM. Presenilin-dependent gamma-secretase processing of beta-amyloid precursor protein at a site corresponding to the S3 cleavage of Notch. EMBO Rep 2001; 2: 835-841
147. Yu C, Kim SH, Ikeuchi T, et al. Characterization of a presenilin-mediated amyloid precursor protein carboxyl-terminal fragment gamma. Evidence for distinct mechanisms involved in gamma -secretase processing of the APP and Notch1 transmembrane domains. J Biol Chem 2001; 276: 43756-43760
148. Weidemann A, Eggert S, Reinhard FB, Vogel M, Paliga K, Baier G. A novel epsilon-cleavage within the transmembrane domain of the Alzheimer amyloid precursor protein demonstrates homology with Notch processing. Biochemistry 2002; 41: 2825-2835
149. Passer B, Pellegrini L, Russo C, et al. Generation of an apoptotic intracellular peptide by gamma-secretase cleavage of Alzheimer's amyloid beta protein precursor. J Alzheimers Dis 2000; 2: 289-301.
150. Hardy J. Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci 1997; 20: 154-159
151. St. George-Hyslop PH, Petit A. Molecular biology and genetics of Alzheimer's disease. C R Biol 2005; 328: 119-130
152. Ohyagi Y, Yamada T, Nishioka K, et al. Selective increase in cellular A β42 is related to apoptosis but not necrosis. Neuroreport 2000; 11: 167-171
153. Li Y, Dudek J, Guiard B, Pfanner N, Rehling P, Voos W. The presequence translocase-associated protein import motor of mitochondria. Pam16 functions in an antagonistic manner to Pam18. J Biol Chem 2004; 279: 38047-38054
154. Tamagno E, Parola M, Bardini P, et al. β-Site APP cleaving enzyme up-regulation induced by 4-hydroxynonenal is mediated by stress-activated protein kinases pathways. J Neurochem 2005; 92: 628-636
155. Schapira AH. Pathogenesis of Parkinson's disease. Baillieres Clin Neurol 1997; 6: 15-36.
156. Sherer TB, Betarbet R, Greenamyre JT. Pathogenesis of Parkinson's disease. Curr Opin Investig Drugs 2001; 2: 657-662
157. Schulz JB, Falkenburger BH. Neuronal pathology in Parkinson's disease. Cell Tissue Res 2004; 318: 135-147
158. Gandhi S, Wood NW. Molecular pathogenesis of Parkinson's disease. Hum Mol Genet 2005; 14: 2749-2755
159. Przedborski S. Pathogenesis of nigral cell death in Parkinson's disease. Parkinsonism Relat Disord 2005; 11: S3-S7. (Pubitemid 40693571)
160. Vila M, Przedborski S. Targeting programmed cell death in neu-rodegenerative diseases. Nat Rev Neurosci 2003; 4: 365-375 (Pubitemid 37280175)
161. Perier C, Tieu K, Guegan C, et al. Complex I deficiency primes Bax-dependent neuronal apoptosis through mitochondrial oxidative damage. Proc Natl Acad Sci USA 2005; 102: 19126-19131
162. Perier C, Bové J, Wu D, et al. Two molecular pathways initiate mitochondria-dependent dopaminergic neurodegeneration in experimental Parkinson's disease. Proc Natl Acad Sci USA 2007; 104: 8161-8166
163. Jones JM, Datta P, Srinivasula SM, et al. Loss of Omi mitochondrial protease activity causes the neuromuscular disorder of mnd2 mutant mice. Nature 2003; 425: 721-727
164. Martins LM, Morrison A, Klupsch K, et al. Neuroprotective role of the Reaper-related serine protease HtrA2/Omi revealed by targeted deletion in mice. Mol Cell Biol 2004; 24: 9848-9862
165. Strauss KM, Martins LM, Plun-Favreau H, et al. Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease. Hum Mol Genet 2005; 14: 2099-2111
166. Plun-Favreau H, Klupsch K, Moisoi N, et al. The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1. Nature Cell Biol 2007; 9: 1243-1252
167. Duchen MR, Valdeolmillos M, O'Neill SC, Eisner DA. Effects of metabolic blockade on the regulation of intracellular calcium in dissociated mouse sensory neurones. J Physiol 1990; 424: 41l-26.
168. 2+ exchange buffer glutamate-induced calcium loads in cultured cortical neurons. J Neurosci 1995; 15: 1318-1328
169. Jacobson J, Duchen MR. Interplay between mitochondria and cellular calcium signalling. Mol Cell Biochem 2004; 256-257: 209-218
170. 2+ network. J Cell Biol 1997; 136: 833-844
171. Johnson JD, Chang JP. Calcium buffering activity of mitochondria controls basal growth hormone secretion and modulates specific neuropeptide signaling. Cell Calcium 2005; 37: 573-581
172. Sullivan PG, Balke CW, Esser KA. Mitochondrial buffering of calcium in the heart-Potential mechanism for linking cyclic energetic cost with energy supply? Circ Res 2006; 99: 109-110
173. McCormack JG, Halestrap AP, Denton RM. Role of calcium ions in regulation of mammalian intramitochondrial metabolism. Physiol Rev 1990; 70: 391-425.
174. 2+ controls slow NAD(P)H oscillations in glucose-stimulated mouse pancreatic islets. J Physiol 2006; 572: 379-392
175. Orrenius S, Zhivotovsky B, Nicotera P. Regulation of cell death: the calcium-apoptosis link. Mol Cell Biol 2003; 4: 552-565
176. Hanson CJ, Bootman MD, Roderick HL. Cell signalling: IP3 receptors channel calcium into cell death. Curr Biol 2004; 14: R933-R935.
177. 2+: molecular determinants and functional consequences. Physiol Rev 2006; 86: 369-408.
178. Moudy AM, Handran SD, Goldberg MP, et al. Abnormal calcium homeostasis and mitochondrial polarization in a human encepha-lomyopathy. Proc Natl Acad Sci USA 1995; 92: 729-733
179. Leissring MA, Akbari Y, Fanger CM, Cahalan MD, Mattson MP, LaFerla FM. Capacitative calcium entry deficits and elevated luminal calcium content in mutant presenilin-1 knockin mice. J Cell Biol 2000; 149: 793-798
180. Yoo AS, Cheng I, Chung S, et al. Presenilin-mediated modulation of capacitative calcium entry. Neuron 2000; 27: 561-572
181. Schneider I, Reverse D, Dewachter I, et al. Mutant presenilins disturb neuronal calcium homeostasis in the brain of transgenic mice, decreasing the threshold for excitotoxicity and facilitating long-term potentiation. J Biol Chem 2001; 276: 11539-11544
182. Herms J, Schneider I, Dewachter I, Caluwaerts N, Kretzschmar H, Van Leuven F. Capacitive calcium entry is directly attenuated by mutant presenilin-1, independent of the expression of the amyloid precursor protein. J Biol Chem 2003; 278: 2484-2489
183. Smith IF, Green KN, LaFerla FM. Calcium dysregulation in Alzheimer's disease: Recent advances gained from genetically modified animals. Cell Calcium 2005; 38: 427-437
184. Hamid R, Kilger E, Willem M, et al. Amyloid precursor protein intracellular domain modulates cellular calcium homeostasis and ATP content. J Neurochem 2007; 102: 1264-1275
185. Ichas F, Jouaville LS, Sidash SS, Mazat JP, Holmuhamedow EL. Mitochondrial calcium spiking: A transduction mechanism based on calcium-induced permeability transition involved in cell calcium signalling. FEBS Lett 1994; 348: 211-215
186. 2+ responses. Science 1998; 280: 1763-1766
187. Csordas G, Thomas AP, Hajnoczky G. Quasi-synaptic calcium signal transmission between endoplasmic reticulum and mitochondria. EMBO J 1999; 18: 96-108.
188. Lin X, Varnai P, Csordas G, et al. Control of calcium signal propagation to the mitochondria by Inositol 1,4,5-Trisphosphate-binding Proteins J Biol Chem 2005; 280: 12820-12832
189. Arnaudeau S, Frieden M, Nakamura K, Castelbou C, Michalak M, Demaurex N.
190. 2+ elevation during agonist stimulation. J Biol Chem 2003; 278: 44769-44779
191. 2+ refilling of the endoplasmic reticulum. J Biol Chem 2005; 280: 12114-12122
192. Gincel D, Zaid H, Shoshan-Barmatz V. Calcium binding and trans-location by the voltage-dependent anion channel: a possible regulatory mechanim in mitochondrial function. Biochem J 2001; 358: 147-155
193. 2+-dependent control of the permeability properties of the mitochondrial outer membrane and VDAC. J Biol Chem 2006; 281: 17347-17358
194. Cheng EH, Sheiko TV, Fisher JK, Craigen WJ, Korsmeyer SJ. VDAC2 inhibits BAK activation and mitochondrial apoptosis. Science 2003; 301: 513-517
195. Colombini M. VDAC: the channel at the interface between mitochondria and the cytosol. Mol Cell Biochem 2004; 256-257: 107-115
196. Lemasters JJ, Holmuhamedov E. Voltage-dependent anion channel (VDAC) as mitochondrial governator-Thinking outside the box. Biochim Biophys Acta 2006; 1762: 181-190
197. 2+channels. J Cell Biol 2006; 175: 901-911
198. Gunter KK, Gunter TE. Transport of calcium by mitochondria. J Bioenerg Biomembr 1994; 26: 471-485
199. Gunter TE, Yule DI, Gunter KK, Eliseev RA, Salter JD. Calcium and mitochondria. FEBS Lett 2004; 567: 96-102.
200. Kirichok Y, Krapivinsky G, Clapham DE. The mitochondrial calcium uniporter is a highly selective ion channel. Nature 2004; 427: 360-364
201. Kann O, Kovacs R. Mitochondria and neuronal activity. Am J Physiol Cell Physiol 2007; 292: C641-C657.
202. 2+ as a key regulator of cell life and death. Cell Death Differ 2007; 14: 1267-1274
203. 2+ uniporter revealed by the p38 mitogen-activated protein kinase inhibitor SB202190. FASEB J 2002; 16: 1955-1957.
204. 2+ signals by protein kinase C isozymes. J Cell Biol 2004; 165: 223-232
205. Montero M, Lobatón CD, Hernández-SanMiguel E, et al. Direct activation of the mitochondrial calcium uniporter by natural plant flavonoids. Biochem J 2004; 384: 19-24.
206. 2+ uptake by estrogen receptor agonists and antagonists. Br J Pharmacol 2005; 145: 862-871
207. 2+-release and oscillations by mitochondrial uniporter stimulation. J Physiol 2007; 580: 39-49.
208. Sparagna GC, Gunter KK, Sheu SS, Gunter TE. Mitochondrial calcium uptake from physiological-type pulses of calcium. A description of the rapid uptake mode. J Biol Chem 1995; 270: 27510-27515
209. 2+ concentration. Curr Biol 2006; 16: 1672-1677
210. Pfeiffer DR, Gunter TE, Eliseev R, Broekemeier KM, Gunter KK. Release of ca2+ from mitochondria via the saturable mechanisms and the permeability transition. IUBMB Life 2001; 52: 205-212
211. Rizzuto R, Bernardi P, Pozzan T. Mitochondria as all-round players of the calcium game. J Physiol 2000; 529: 37-47.
212. 2+ antiport by matrix ph. Arch Biochem Bio-phys 1991; 291: 383-389
213. Brierley GP, Baysal K, Jung DW. Cation transport systems in mitochondria: Na and K uniports and exchangers. J Bioenerg Biomembr 1994; 26: 519-526
214. Kaftan EJ, Xu T, Abercrombie RF, Hille B. Mitochondria shape hormonally induced cyoplasmic calcium oscillations and modulate exocytosis. J Biol Chem 2000; 275: 25465-25470
215. Sedova M, Blatter LA. Intracellular sodium modulates mitochondiral calcium signalling in vascular endothelial cells. J Biol Chem 2000; 275: 35402-35407
216. 2+ clearance from neurons. Front Biosci 2002; 7: 1255-1279
217. Jouaville LS, Ichas F, Mazat J. Modulation of cell calcium signals by mitochondria. Mol Cell Biochem 1998; 184: 371-376
218. Gunter TE, Buntinas L, Sparagna G, Eliseev R, Gunter K. Mitochondria and calcium transport: mechanisms and functions. Cell Calcium 2000; 28: 285-296
219. Smaili SS, Hsu YT, Youle RJ, Russell JT. Mitochondria in signalling and apoptosis. J Bioenerg Biomembr 2000; 32: 35-46.
220. Robertson JD, Zhivotovsky B, Gogvadze V, Orrenius S. Outer mitochondrial membrane permeabilization: an open-and-shut case? Cell Death Differ 2003 10: 485-487
221. Altschuld RA, Hohl CM, Castillo LC, Garleb AA, Starling RC, Brierley GP. Cyclosporin inhibits mitochondrial calcium efflux in isolated adult rat ventricular cardiomyocytes. Am J Physiol 1992; 262: H1699-H1704.
222. Zoratti M, Szabo I. The mitochondrial permeability transition. Biochim Biophys Acta 1995; 1241: 139-176
223. Bernadi P, Petronilli V. The permeability transition pore as a mitochondrial calcium release channel: A critical appraisal. J Bioenerg Biomembr 1996; 28: 131-138
224. Ichas F, Jouaville LS, Mazat JP. Mitochondria are excitable organelles capable of generating and conveying electrical and calcium signals. Cell 1997; 89: 1145-1153
225. 2+ homeostasis in the regulaion of apoptotic and necrotic cell deaths. Cell Calcium 2000; 28: 107-117
226. Demaurex N, Distelhorst C. Cell biology. Apoptosis - the calcium connection. Science 2003; 300: 65-67
227. Annis MG, Yethon JA, Leber B, Andrews DW. There is more to life and death mitochondria: Bcl-2 proteins at the endoplasmic reticulum. Biochim Biophys Acta 2004; 1644: 115-123
228. Hanson CJ, Bootman MD, Roderick HL. Cell signalling: IP3 receptors channel calcium into cell death. Curr Biol 2004; 14: R933-R935.
229. Walter L, Hajnoczky G. Mitochondria and endoplasmic reticulum: the lethal interorganelle cross-talk. J Bioenerg Biomembr 2005; 137: 191-206.
230. 2 directly activates inositol 1,4,5-triphosphate receptors in endothelial cells. Redox Rep 2005; 10: 29-36.
231. Garcia N, Garcia JJ, Correa F, Chavez E. The permeability transition pore as a pathway for the release of mitochondrial DNA. Life Sciences 2005; 70: 2873-2880
232. Garcia N, Chavez E. Mitochondrial DNA fragments released through the permeability transition pore correspond to specific gene size. Life Sciences 2007; 81: 1160-1166
233. Zong WX, Li C, Hatzivassiliou G, et al. Bax and Bak can localize to the endoplasmic reticulum to initiate apoptosis. J Cell Biol 2003; 162: 59-69.
234. Scorrano L, Oakes SA, Opferman JT, et al. BAX and BAK regulation of endoplasmic reticulum : a control point for apoptosis. Science 2003; 300: 135-139
235. Oakes SA, Scorrano L, Opferman JT, et al. Proapoptotic BAX and BAK regulate the type 1 inositol triphosphate receptor and calcium leak from the endoplasmic reticulum. Proc Natl Acad Sci USA 2005; 102: 105-110
236. White C, Li C, Yang J, et al. The endoplasmic reticulum gateway to apoptosis by Bcl-X(L) modulation of the InsP3R. Nat Cell Biol 2005; 7: 1021-1028
237. 2+ signalling which do not depend on their putative pore-forming region. J Biol Chem 2004; 279: 54581-54589
238. Chen R, Valencia I, Zhong F, et al. Bcl-2 functionally interacts with inositol 1,4,5-triphosphate receptors to regulate calcium release from the ER in response to inositol 1,4,5-triphosphate. J Cell Biol 2004; 166: 193-203.
239. 2+ signals according to the strength of T cell receptor activation. J Cell Biol 2006; 172: 127-137
240. 2+ concentration within the endoplasmic reticulum. Proc Nat Acad Sci USA 2000; 97: 5723-5728
241. 2+ influx in Bcl-2 overexpressing cells. J Cell Biol 2000; 148: 857-862
242. Vanden Abeele F, Skryma R, Shuba Y, et al. Bcl-2-dependent modulation of Ca(2+) homeostasis and store-operated channels in prostate cancer cells. Cancer Cell 2002; 1: 169-179
243. Rizzuto R, Pinton P, Ferrari D, et al. Calcium and apoptosis: facts and hypotheses. Oncogene 2003; 22: 8619-8627
244. Xu LP, Kong DJ, Zhu LP, Zhu WJ, Andrews DW, Kuo TH. Suppression of IP3-mediated calcium release and apoptosis by Bcl-2 involves the participation of protein phosphatase 1. Mol Cell Bio-chem 2007; 295: 153-165
245. Brini M, Pinton P, King MP. A calcium signalling defect in the pathogenesis of a mitochondrial DNA inherited oxidative pho-sophorylation deficiency. Nature Med 1999; 5: 951-954
246. Peterson C, Goldman JE. Alterations in calcium content and biochemical processes in cultured skin fibroblasts from aged and Alzheimer donors. Proc Natl Acad Sci USA 1986; 83: 2758-2762
247. Peterson C, Ratan RR, Shelanski ML, Goldman JE. Altered response of fibroblasts from aged and Alzheimer Donors to drugs that elevate cytosolic free calcium. Neurobiol Aging 1988; 9: 261-266
248. Huang HM, Toral-Barza L, Thaler H, Tofel-Grehl B, Gibson GE. Inositol phosphates and intracellular calcium after bradykinin stimulation in fibroblasts from young, normal aged, and Alzheimer donors. Neurobiol Aging 1991; 12: 469-473
249. McCoy KR, Mullins RD, Newcomb TG, et al. Serum-and bradykinin-induced calcium transients in familial Alzheimer's fibroblasts. Neurobiol Aging 1993; 14: 447-455
250. Etcheberrigaray R, Gibson GE, Alkon DL. Molecular mechanisms of memory and the pathophysiology of Alzheimer's disease. Ann NY Acad Sci 1994; 747: 244-255
251. 2+ mobilization is altered in fibroblasts from patients with Alzheimer disease. Proc Natl Acad Sci USA 1994; 91: 534-538
252. Kumar U, Dunlop D, Richardson JS. Mitochondria from Alzheimer's fibroblasts show decreased uptake of calcium and increased sensitivity to free radicals. Life Sci 1994; 54: 1855-1860
253. Sheehan JP, Swerdlow RH, Miller SW, et al. Calcium homeostasis and reactive oxygen species production in cells transformed by mitochondria from individuals with sporadic Alzheimer's Disease. J Neurosci 1997; 17: 4612-4622
254. Sheehan JP, Swerdlow RH, Parker WD, Miller SW, Davis RE, Tuttle JB. Altered calcium homeostasis in cells transformed by mitochondria from individuals with Parkinson's Disease. J Neurochem 1997; 68: 1221-1233
255. Lai JCK, DiLorenzo JC, Sheu KFR. Pyruvate dehydrogenase complex is inhibited in calcium-loaded cerebrocortical mitochondria. Neurochem Res 1988; 13: 1043-1048
256. Siman R, Noszek JC. Excitatory amino acids activate calpain I and induce structural protein breakdown in vivo. Neuron 1988; 1: 279-287
257. Carroll JM, Toral-Barza L, Gibson G. Cytosolic free calcium and gene expression during chemical hypoxia. J Neurochem 1992; 59: 1836-1843
258. Lipton SA, Choi YB, Pan ZH, et al. A redox-base mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 1993; 364: 626-632
259. Verity MA. Mechanisms of phospholipase A2 activation and neuronal injury. Ann NY Acad Sci 1993; 679: 110-120
260. 2+/Mg2+-dependent endonuclease associated with apoptosis. J Immunol 1996; 156: 922-931
261. Tikka TM, Koistinaho JE. Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia. J Immunol 2001; 166: 7527-7533
262. Song Y, Wei EQ, Zhang WP, Zhang L, Liu JR, Chen Z. Minocycline protects PC12 cells from ischemic-like injury and inhibits 5-lipoxygenase activation. Neuroreport 2004; 15: 2181-2184
263. Nirmalananthan N, Greensmith L. Amyotrophic lateral sclerosis: recent advances and future therapies. Curr Opin Neurol 2005; 18: 712-719
264. Fernandez-Gomez FJ, Galindo MF, Gomez-Lazaro M, et al. Involvement of mitochondrial potential and calcium buffering capacity in minocycline cytoprotectiveactions. Neuroscience 2005; 133: 959-967
265. Mansson R, Hansson MJ, Morota S, Uchino H, Ekdahl CT, Elmer E. Re-evaluation of mitochondrial permeability transition as a primary neuroprotective target of minocycline. Neurobiology of Disease 2007; 25: 198-205.
266. Florez-Duquet M, McDonald RB. Cold-induced thermoregulation and biological aging. Physiol Rev 1998; 78: 339-358
267. Gilca M, Stoian I, Atanasiu V, Virgolici B. The oxidative hypothesis of senescence. J Postgrad Med 2007; 53: 207-213
268. Harman D. The biologic clock: the mitochondria? J Am Geriatr Soc 1972; 20: 145-147
269. Genova ML, Pich MM, Bernacchia A, et al. The mitochondrial production of reactive oxygen species in relation to aging and pathology. Ann NY Acad Sci 2004; 1011: 86-100.
270. Lee HC, Pang CY, Hsu HS, Wei YH. Differential accumulations of 4,977 bp deletion in mitochondrial DNA of various tissues in human ageing. Biochim Biophys Acta 1994; 1226: 37-43.
271. Lee HC, Wei YH. Mutation and oxidative damage of mitochondrial DNA and defective turnover of mitochondria in human ageing. J Formos Med Assoc 1997; 96: 770-778
272. Szibor M, Holtz J. Mitochondrial ageing. Basic Res Cardiol 2003; 98: 210-218
273. Babalan RS, Nemoto S, Finkel T. Mitochondria, oxidants and aging. Cell 2005; 12: 483-495
274. Miquel J, Economos AC, Fleming J, Johnson Jr JE. Mitochondrial role in cell ageing. Exp Gerontol 1980; 15: 575-591
275. Beckman KB, Ames BN. The free radical theory of aging matures. Physiol Rev 1998; 78: 547-581
276. Dufour E, Larsson N. Understanding aging: revealing order out of chaos. Biochim Biophys Acta 2004; 1658: 122-132
277. Junqueira VBC, Barros SBM, Chan SS, et al. Aging and oxidative stress. Mol Aspects Med 2004; 25: 5-16.
278. Gedik CM, Grant G, Morrice PC, Wood SG, Collins AR. Effects of age and dietary restriction on oxidative DNA damage, antioxidan protection and DNA repair in rats. Eur J Nutr 2005; 44: 263-272
279. Balaban R, Nemoto S, Finkel T. Mitochondria, oxidants, and aging. Cell 2006; 120: 483-495
280. Vazquez-Memije ME, Capin R, Tolosa A, El-Hafidi M. Analysis of age-associated changes in mitochondrial free radical generation by rat testis. Mol Cell Biochem 2008; 307: 23-30.
281. Bogenhagen DF. Repair of mtDNA in vertebrates. Am J Hum Genet 1999; 64: 1276-1281
282. Wei YH, Lee HC. Oxidative stress, mitochondrial DNA mutation, and impairment of antioxidant enzymes in aging. Exp Biol Med 2002; 227: 671-682
283. Kang D, Hamasaki N. Mitochondrial oxidative stress and mitochondrial DNA. Clin Chem Lab Med 2003; 41: 1281-1288
284. Sohal RS, Ku HH, Agarwal S, Forster MJ, Lal H. Oxidative damage, mitochondrial oxidant generation and antioxidant defenses during aging and in response to food restriction in the mouse. Mech Ageing Dev 1994; 74: 121-133
285. Sohal RS, Sohal BH, Orr WC. Mitochondrial superoxide and hydrogen peroxide generation, protein oxidative damage, and longevity in different species of flies. Free Rad Biol Med 1995; 19: 499-504.
286. Suh JH, Shigeno ET, Morrow JD, et al. Oxidative stress in the aging rat heart is reversed by dietary supplementation with (R)-α-lipoic acid. FASEB J 2001; 15: 700-706
287. Suh JH, Heath SH, Hagen TM. Two subpopulations of mitochondria in the aging rat heart display heterogenous levels of oxidative stress. Free Radic Biol Med 2003; 35: 1064-1072
288. Judge S, Jang YM, Smith A, Hagen T, Leeuwenburgh C. Age-associated increases in oxidative stress and antioxidant enzyme activities in cardiac interfibrillar mitochondria: implications for the mitochondrial theory of aging. FASEB J 2005; 19: 419-421
289. Judge S, Jang YM, Smith A, et al. Exercise by lifelong voluntary wheel running reduces subsarcolemmal and interfibrillar mitochon-drial hydrogen peroxide production in the heart. Am J Physiol Regul Integr Comp Physiol 2005; 289: R1564-R1572.
290. Kwak HB, Song W, Lawler JM. Exercise training attenuates age-induced elevation in Bax/Bcl-2 ratio, apoptosis, and remodeling in the rat heart. FASEB J 2006; 20: 791-793
291. Humphreys V, Martin RM, Ratcliffe B, et al. Age-related increases in DNA repair and antioxidant protection: A comparison of the Boyd Orr Cohort of elderly subjects with a younger population sample. Age and Ageing 2007; 36: 521-526
292. Sun J, Folk D, Bradley TJ, Tower J. Induced overexpression of mitochondrial Mn-superoxide dismutase extends the life span of adult Drosophila melanogaster. Genetics 2002; 161: 661-672
293. Ruan H, Dong Tang X, Chen M, et al. High-quality life extension by the enzyme peptide methionine sulfoxide reductase. Proc Natl Acad Sci USA 2002; 99: 2748-2753
294. Schriner SE, Linford NJ, Martin GM, et al. Extension of murine life span by overexpression of catalase targeted to mitochondria. Science 2005; 308: 1909-1911
295. Quick KL, Ali SS, Arch R, Xiong C, Wozniak D, Dugan LL. A carboxyfullerene SOD mimetic improves cognition and extends the lifespan of mice. Neurobiol Aging 2008; 29: 117-128
296. Kashima M. Effects of catechins on superoxide and hydroxyl radical. Chem Pharm Bull 1999; 47: 279-283
297. Skrzydlewska E, Ostrowska J, Farbiszewski R, Michalak K. Protective effect of green tea against lipid peroxidation in the rat liver, blood serum and the brain. Phytomedicine 2002; 9: 232-238
298. Unno K, Takabayashi F, Kishido T, Oku N. Suppressive effect of green tea catechins on morphologic and functional regression of the brain in aged mice with accelerated senescence (SAMP10). Exp Gerontol 2004; 39: 1027-1034
299. Unno K, Takabayashi F, Yoshida H, et al. Daily consumption of green tea catechin delays memory regression in aged mice. Bioger-ontology 2006; 8: 89-95.
300. Kishido T, Unno K, Yoshida H, et al. Decline in glutathione peroxidase activity is a reason for brain senescence: consumption of green tea catechin prevents the decline in its activity and protein oxidative damage in ageing mouse brain. Biogerontology 2007; 8: 423-430
301. Sohal RS, Weindruch R. Oxidative stress, caloric restriction and aging. Science 1996; 273: 59-63.
302. Hamilton ML, Van Remmen H, Drake JA, et al. Does oxidative damage to DNA increase with age? Proc Natl Acad Sci USA 2001; 98: 10469-10474
303. Martin B, Mattson MP, Maudsley S. Caloric restriction and intermittent fasting: two potential diets for successful brain aging. Ageing Res Rev 2006; 5: 332-353
304. Gomez J, Caro P, Naudi A, Portero-Otin M, Pamplona R, Barja G. Effect of 8.5 % and 25 % caloric restriction on mitochondrial free radical production and oxidative stress in rat liver. Biogereontology 2007; 8: 555-566
305. Weindruch RW, Walford RL. The Retardation of Aging and Disease by Dietary Restriction. Springfield, IL: Thomas, 1988.
306. Bordone L, Guarente L. Calorie restriction, SIRT1 and metabolism: understanding longevity. Nat Rev Mol Cell Biol 2005; 6: 298-305. (Pubitemid 40516896)
307. Duan W, Mattson MP. Dietary restriction and 2-deoxyglucose administration improve behavioral outcome and reduce degeneration of dopaminergic neurons in models of Parkinson's disease. J Neurosci Res 1999; 57: 195-206.
308. Zhu HY, Guo Q, Mattson MP. Dietary restriction protects hippo-campal neurons against the death-promoting action of a presenili-1 mutation. Brain Res 1999; 842: 224-229
309. Mattson MP. Will caloric restriction and folate protect against AD and PD ? Neurology 2003; 60: 690-695
310. Barja G, Cadenas S, Rojas C, Lopez-Torres M, Perez-Campo R. A decrease of free radical production near critical targets as a cause of maximum longevity in animals. Comp Biochem Physiol 1994; A108: 501-512
311. Barja G. Endogenous oxidative stress: relationship to aging, longevity and caloric restriction. Ageing Res Rev 2002; 1: 397-411.
312. 2 generation in isolated mitochondria. J Bioenerg Biomembr 2002; 34: 227-233
313. Lambert AJ, Wang B, Yardley J, Edwards J, Merry BJ. The effect of aging and caloric restriction on mitochondrial protein density and oxygen consumption. Exp Gerontol 2004; 39: 289-292
314. Sohal RS, Agarwal S, Candas M, Forster MJ, Lal H. Effect of age and caloric restriction on DNA oxidative damage in different tissues of C57BL/6 mice. Mech Ageing Dev 1994; 76: 215-224
315. Gredilla R, Barja G. The role of oxidative stress in relation to caloric restriction and longevity. Endocrinology 2005; 146: 3713-3717
316. 2 production and oxidative damage. Cardiovasc Res 2007; 74: 456-465
317. Leeuwenburgh C, Wagner P, Holloszy JO, Sohal RS, Heinecke JW. Caloric restriction attenuates dityrosine cross-linking of cardiac and skeletal muscle proteins in aging mice. Arch Biochem Biophys 1997; 346: 74-80.
318. Pamplona R, Portero-Otin M, Bellmun MJ, Gredilla R, Barja G. Aging increases Nε-(carboxymethyl)lysine and caloric restriction decreases Nε-(carboxyethyl)lysine and Nε-(malondialdehyde)ly-sine in rat heart mitochondrial proteins. Free Radic Res 2002; 36: 47-54.
319. Pamplona R, Portero-Otin M, Requena J, Gredilla R, Barja G. Oxidative, glycoxidative and lipoxidative damage to rat heart mitochondrial proteins is lower after 4 months of caloric restriction than in age-matched controls. Mech Ageing Dev 2002; 123: 1437-1446
320. Nisoli E, Tonello C, Cardile A, et al. Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS. Science 2005; 310: 314-317
321. Lopez-Lluch G, Hunt N, Jones B, et al. Calorie restriction induces mitochondrial biogenesis and bioenergetic efficiency. Proc Natl Acad Sci USA 2006; 103: 1768-1773
322. Pamplona R, Portero-Otin M, Requena J, Gredilla R, Barja G. Oxidative, glycoxidative and lipoxidative damage to rat heart mitochondrial proteins is lower after 4 months of caloric restriction than in age-matched controls. Mech Ageing Dev 2002; 123: 1437-1446.
323. Mizuno Y, Ohta S, Tanaka M, et al. Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. Biochem Biophys Res Commun 1989; 163: 1450-1455
324. Schapira AHV, Cooper JM, Dexter D, Jenner P, Clark JB, Marsden CD. Mitochondrial complex I deficiency in Parkinson's disease. Lancet 1989; 1: 1269.
325. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 2004; 350: 664-671
326. Keeney PM, Xie J, Capaldi RA, Bennett JP Jr. Parkinson's disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled. J Neurosci 2006; 26: 5256-5264
327. Mogensen M, Sahlin K, Fernstrom M, et al. Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes. Diabetes 2007; 56: 1592-1599
328. Vazquez-Memije ME, Shanske S, Santorelli FM, Kranz-Eble P, DeVivo DC, DiMauro S. Comparative biochemical studies of AT-Pases in cells from patients with the T8993G or T8993C mitochondrial DNA mutations. J Inherit Metab Dis 1998; 21: 829-836
329. Pallotti F, Baracca A, Hernandez-Rosa E, et al. Biochemical analysis of respiratory function in cybrid cell lines harbouring mitochondrial DNA mutations. Biochem J 2004; 384: 287-293
330. Baracca A, Sgarbi G, Mattiazzi M, et al. Biochemical phenotypes associated with the mitochondrial ATP6 gene mutations at nt8993. Biochim Biophys Acta -Bioenergetics 2007; 1767: 913-919
331. Kirby DM, Kahler SG, Freckmann ML, Reddihough D, Thorburn DR. Leigh disease caused by the mitochondrial DNA G14459A mutation in unrelated families. Ann Neurol 2000; 48: 102-104
332. Taylor RW, Singh-Kler R, Hayes CM, Smith PE, Turnbull DM. Progressive mitochondrial disease resulting from a novel missense mutation in the mitochondrial DNA ND3 gene. Ann Neurol 2001; 50: 104-107
333. Taylor RW, Morris AA, Hutchinson M, Turnbull DM. Leigh disease associated with a novel mitochondrial DNA ND5 mutation. Eur J Hum Genet 2002; 10: 141-144
334. Chol M, Lebon S, Benit P, et al. The mitochondrial DNA G13513A MELAS mutation in the NADH dehydrogenase 5 gene is a frequent cause of Leigh-like syndrome with isolated complex I deficiency. J Med Genet 2003; 40: 188-191
335. Kirby DM, Boneh A, Chow CW, et al. Low mutant load of mitochondrial DNA G13513A mutation can cause Leigh's disease. Ann Neurol 2003; 54: 473-478
336. Lebon S, Chol M, Benit P, et al. Recurrent de novo mitochondrial DNA mutations in respiratory chain deficiency. J Med Genet 2003; 40: 896-899
337. Ugalde C, Triepels RH, Coenen MJ, et al. Impaired complex I assembly in a Leigh syndrome patient with a novel missense mutation in the ND6 gene. Ann Neurol 2003; 54: 665-669
338. McFarland R, Kirby DM, Fowler KJ, et al. De novo mutations in the mitochondrial ND3 gene as a cause of infantile mitochondrial encephalopathy and complex I deficiency. Ann Neurol 2004; 55: 58-64.
339. Sudo A, Honzawa S, Nonaka I, Goto Y. Leigh syndrome caused by mitochondrial DNA G13513A mutation: Frequency and clinical features in Japan. J Hum Genet 2004; 49: 92-96
340. Sarzi E, Brown MD, Lebon S, et al. A novel recurrent mitochon-drial DNA mutation in ND3 gene is associated with isolated complex I deficiency causing Leigh syndrome and dystonia. Am J Genet 2007; 143A: 33-41.
341. Trounce I, Neill S, Wallace DC. Cytoplasmic transfer of the mtDNA nt 8993 T - G (ATP6) point mutation associated with Leigh syndrome into mtDNA-less cells demonstrates cosegregation with a decrease in state III respiration and ADP/O ratio. Proc Natl Acad Sci USA 1994; 91: 8334-8338
342. Houstek J, Klement P, Hermanska J, et al. Altered properties of mitochondrial ATP-synthase in patients with a T-G mutation in the ATPase 6 (subunit a) gene at position 8993 of mtDNA. Bio-chim Biophys Acta 1995; 1271: 349-357
343. Vazquez-Memije ME, Shanske S, Santorelli FM, et al. Comparative biochemical studies in fibroblasts from patients with different forms of Leigh syndrome. J Inherit Metab Dis 1996; 19: 43-50.
344. Manfredi G, Gupta N, Vazquez-Memije ME, et al. Oligomycin induces a decrease in the cellular content of a pathogenic mutation in the human mitochondrial ATPase 6 gene. J Biol Chem 1999; 274: 9386-9391
345. Baracca A, Barogi S, Carelli V, Lenaz G, Solaini G. Catalytic activities of mitochondrial ATP synthase in patients with mito-chondrial DNA T8993G mutation in the ATPase 6 gene encoding subunit a. J Biol Chem 2000; 275: 4177-4182
346. Garcia JJ, Ogilvie I, Robinson BH, Capaldi RA. Structure, functioning, and assembly of the ATP synthase in cells from patients with the T8993G mitochondrial DNA mutation: Comparsion with the enzyme in Rho(0) cells completely lacking mtDNA. J Biol Chem 2000; 275: 11075-11081
347. Sgarbi G, Baracca A, Lenaz G, Valentino LM, Carelli V, Solaini G. Inefficient coupling between proton transport and ATP synthesis may be the pathogenic mechanism for NARP and Leigh syndrome resulting from the T8993G mutation in mtDNA. Biochem J 2006; 395: 493-500.
348. Rak M, Tetaud M, Duvezin-Caubet S, et al. A yeast model of the Neurogenic Ataxia Retinitis Pigmentosa (NARP) T8993G mutation in the mitochondrial ATP synthase-6 gene. J Biol Chem 2007; 282: 34039-34047
349. Nijtmans LG, Henderson NS, Attardi G, Holt IJ. Impaired ATP synthase assembly associated with a mutation in the human ATP synthase subunit 6 gene. J Biol Chem 2001; 276: 6755-6762
350. Carrozzo R, Wittig I, Santorelli FM, et al. Subcomplexes of human ATP synthase mark mitochondrial biosynthesis disorders. An Neurol 2006; 59: 265-275
351. Schon EA, Santra S, Pallotti F, Girvin ME. Pathogenesis of primary defects in mitochondrial ATP synthesis. Semin Cell Dev Biol 2001; 12: 441-448
352. 0-ATP synthase without preventing enzyme assembly and oligomerization. J Biol Chem 2007; 282: 1051-1058
353. Brown MD, Trounce IA, Jun AS, Allen JC, Wallace DC. Functional analysis of lymphoblast and cybrid mitochondria containing the 3460, 1178, or 1448 Leber's hereditary optic neuropathy mtDNA mutation. J Biol Chem 2000; 275: 39831-39836
354. Carelli V, Rugolo M, Sgarbi G, et al. Bioenergetics shapes cellular death pathways in Leber's hereditary optic neuropathy: a model of mitochondrial neurodegeneration. Biochim Biophys Acta 2004; 1658: 172-179
355. Heddi A, Stepien G, Benke PJ, Wallace DC. Coordinate induction of energy gene expression in tissues of mitochondrial disease patients. J Biol Chem 1999; 274: 22968-22976
356. Joseph A, Rungi AA, Robinson BH, Hood DA. Compensatory responses of protein import and transcription factor expression in mitochondrial DNA defects. Am J Cell Physiol 2004; 286: C867-C875.
357. Huckriede A, Agsteribbe, E. Decreased synthesis and inefficient mitochondiral import of Hsp60 in a patient with a mitochondrial encephalomyopathy. Biochim Biophys Acta 1994; 1227: 200-206
358. Voisine C, Craig EA, Zufall N, von Ahsen O, Pfanner N, Voos W. The protein import motor of mitochondria: unfolding and trapping of preproteins are distinct and separable function of matrix Hsp70. Cell 1999; 97: 565-574
359. Colavecchia M, Christie LN, Kanwar YS, Hood DA. Functional consequences of thyroid hormone-induced changes in the mito-chondrial protein import pathway. Am J Physiol Endocrinol Metab 2003; 284: E29-E35.
360. Barth C, Le P, Fisher PR. Mitochondrial biology and disease in Dictyostelium. Int Rev Cytol 2007; 263: 207-52.
361. Bokko PB, Francione L, Bandala-Sanchez E, et al. Diverse pathologies in mitochondrial disease are caused by AMP-activated protein kinase signalling. Molec Biol Cell 2007; 18: 1874-1886
362. Hardie DG, Sakamoto K. AMPK: A key sensor of fuel and energy status in skeletal muscle. Physiology 2006; 21: 48-60.
363. Hardie DG, Hawley SA. AMP-activated protein kinase: the energy charge hypothesis revisited. BioEssays 2001; 23: 1112-1119.
364. Hardie DG. The AMP-activated protein kinase pathway -new players upstream amd downstream. J Cell Sci 2004; 117: 5479-5487
365. Kahn BB, Alquiier T, Carling D, Hardie DG. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab 2005; 1: 15-25.
366. Zhou G, Myers R, Li Y, et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 2001; 108: 1167-1174
367. Hawley SA, Boudeau J, Reid JL, et al. Complexes between the LKB1 tumor suppressor, STRAD α/β and MOD are α/β are upstream kinases in the AMP-activated protein kinase cascade. J Biol 2003; 2: 28.
368. Kukidome D, Nishikawa T, Sonada K, et al. Activation of AMP-activated protein kinase reduces hyperglycemia-induced mitochon-drial reactive oxygen species production and promotes mitochon-drial biogenesis in human umbilical vein endothelial cells. Diabetes 2006; 55: 120-127
369. Chou S-Z, Lee Y-C, Chen H-M, et al. CGS21680 attenuates symptoms of Huntington's disease in a transgenic mouse model. J. Neu-rochem 2005; 93: 310-320
370. Lopez-Lopez C, Dietrich MO, Metzger F, Loetscher H, Torres-Aleman I. Disturbed cross talk between Insulin-like Growth Factor I and AMP-activated Protein Kinase as a possible cause of vascular dysfunction in the Amyloid Precursor Protein/Presenilin 2 mouse model of Alzheimer's disease. J Neurosci 2007; 27: 824-831
371. Francione L, Smith PK, Accari SL, et al. Legionella pneumophila multiplication is enhanced by chronic AMPK signalling in mitochondrially diseased Dictyostelium cells. Dis Model Mech 2009; 2: 479-489